| __timestamp | Taro Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 55430000 | 1488000000 |
| Thursday, January 1, 2015 | 65510000 | 1525000000 |
| Friday, January 1, 2016 | 71160000 | 2111000000 |
| Sunday, January 1, 2017 | 70644000 | 1848000000 |
| Monday, January 1, 2018 | 70418000 | 1213000000 |
| Tuesday, January 1, 2019 | 63238000 | 1010000000 |
| Wednesday, January 1, 2020 | 59777000 | 997000000 |
| Friday, January 1, 2021 | 60152000 | 967000000 |
| Saturday, January 1, 2022 | 54540000 | 838000000 |
| Sunday, January 1, 2023 | 52243000 | 953000000 |
| Monday, January 1, 2024 | 64536000 | 998000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. have demonstrated contrasting strategies in this domain. From 2014 to 2023, Teva's R&D expenses have consistently dwarfed Taro's, with Teva investing nearly 20 times more in 2016. However, Teva's spending has seen a downward trend, dropping from its peak in 2016 to a 60% lower figure by 2022. Meanwhile, Taro's R&D investment has remained relatively stable, with a slight decline of about 10% over the same period. This divergence in R&D focus highlights the strategic differences between the two companies, with Teva potentially reallocating resources, while Taro maintains a steady course.
Novo Nordisk A/S or Teva Pharmaceutical Industries Limited: Who Invests More in Innovation?
R&D Insights: How Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc. Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Axsome Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc.
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs MannKind Corporation: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs Novavax, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Incyte Corporation vs Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Exelixis, Inc. vs Taro Pharmaceutical Industries Ltd.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.
Research and Development Investment: Grifols, S.A. vs Taro Pharmaceutical Industries Ltd.
R&D Insights: How MannKind Corporation and Taro Pharmaceutical Industries Ltd. Allocate Funds